Abby Paine

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 3

Top Topics

Cardiovascular Disease

Randomized Controlled Trial

Age Related Macular Degeneration

Diabetic Retinopathy

Top Venues

Diabetes therapy : research, treatment and education of diabetes and related disorders

Diabetes, obesity & metabolism

Endocrinology, diabetes & metabolism

This page only lists publications with an associated author ORCID identifier.

Publications

Shelby Sydnor, Swarnendu Chatterjee, Philip Cooney, Simarjeet Kaur, Thomas Macmillan, Daisy Stewart, Isobel Munro, Cátia Bandeiras, Abby Paine, Federico Felizzi
Efficacy and Safety of Brolucizumab, Aflibercept, and Ranibizumab for the Treatment of Patients with Visual Impairment Due to Diabetic Macular Oedema: A Systematic Review and Network Meta-Analysis. Diabetes therapy : research, treatment and education of diabetes and related disorders (2023)
Lyndon Marc Evans, Linda Mellbin, Pierre Johansen, Jack Lawson, Abby Paine, Anna Sandberg
A population-adjusted indirect comparison of cardiovascular benefits of once-weekly subcutaneous semaglutide and dulaglutide in the treatment of patients with type 2 diabetes, with or without established cardiovascular disease. Endocrinology, diabetes & metabolism 4 (3) (2021)
Richard E Pratley, Andrei-Mircea Catarig, Ildiko Lingvay, Adie Viljoen, Abby Paine, Jack Lawson, Barrie Chubb, Anders Gorst-Rasmussen, Nino Miresashvili
An indirect treatment comparison of the efficacy of semaglutide 1.0 mg versus dulaglutide 3.0 and 4.5 mg. Diabetes, obesity & metabolism 23 (11) (2021)